Setting: An Australian metropolitan TB clinic where treatment for latent tuberculosis infection (LTBI) comprises six months of isoniazid, self-administered but dispensed monthly by the clinic. Objective: To determine the proportion of patients who complete treatment for LTBI and to identify factors associated with non-completion. Methods: Clinical files of all patients receiving treatment for LTBI between 01/2000 and 12/2010 were reviewed. The study population comprised all patients who were commenced on isoniazid as treatment for LTBI. Odds ratios (OR) for completing treatment were estimated by logistic regression. Results: Of 216 patients who commenced isoniazid treatment for LTBI, 16 (75%) completed six months treatment. Fifty-three perc...
SETTING: A large urban tuberculosis (TB) control program. OBJECTIVES: To identify factors associated...
AIM: To survey practices in the diagnosis and management of latent tuberculosis infection (LTBI) in ...
IntroductionIt is essential to strengthen the treatment of latent tuberculosis infection (LTBI) to b...
SETTING: An Australian metropolitan TB clinic where treatment for latent tuberculosis infection (LTB...
An Australian metropolitan TB clinic where treatment for latent tuberculosis infection (LTBI) compri...
Objective: The authors\u27 objective was to document 9-month and previously recommended 6-month trea...
Objectives: The recommended treatment for latent tuberculosis infection is isoniazid for 9 months, b...
Background: Successful treatment of latent tuberculosis infection (LTBI) is essential to reduce tube...
ABSTRACT: Treatment of latent tuberculosis (TB) infection with 3 months of rifampicin/isoniazid is a...
Inclusion criteria were study populations of patients with predominantly pulmonary tuberculosis, cer...
AbstractBackgroundLow adherence to treatment of latent tuberculosis infection (TLTBI) diminishes TB ...
OBJECTIVESTo assess latent tuberculous infection (LTBI) treatment completion rates in a large prospe...
Aim: To survey practices in the diagnosis and management of latent tuberculosis infection (LTBI) in ...
Over the past century, the UK has made significant progress in combating tuberculosis (TB) through i...
Treatment of Latent Tuberculosis Infection (LTBI) is an important component of any TB control strate...
SETTING: A large urban tuberculosis (TB) control program. OBJECTIVES: To identify factors associated...
AIM: To survey practices in the diagnosis and management of latent tuberculosis infection (LTBI) in ...
IntroductionIt is essential to strengthen the treatment of latent tuberculosis infection (LTBI) to b...
SETTING: An Australian metropolitan TB clinic where treatment for latent tuberculosis infection (LTB...
An Australian metropolitan TB clinic where treatment for latent tuberculosis infection (LTBI) compri...
Objective: The authors\u27 objective was to document 9-month and previously recommended 6-month trea...
Objectives: The recommended treatment for latent tuberculosis infection is isoniazid for 9 months, b...
Background: Successful treatment of latent tuberculosis infection (LTBI) is essential to reduce tube...
ABSTRACT: Treatment of latent tuberculosis (TB) infection with 3 months of rifampicin/isoniazid is a...
Inclusion criteria were study populations of patients with predominantly pulmonary tuberculosis, cer...
AbstractBackgroundLow adherence to treatment of latent tuberculosis infection (TLTBI) diminishes TB ...
OBJECTIVESTo assess latent tuberculous infection (LTBI) treatment completion rates in a large prospe...
Aim: To survey practices in the diagnosis and management of latent tuberculosis infection (LTBI) in ...
Over the past century, the UK has made significant progress in combating tuberculosis (TB) through i...
Treatment of Latent Tuberculosis Infection (LTBI) is an important component of any TB control strate...
SETTING: A large urban tuberculosis (TB) control program. OBJECTIVES: To identify factors associated...
AIM: To survey practices in the diagnosis and management of latent tuberculosis infection (LTBI) in ...
IntroductionIt is essential to strengthen the treatment of latent tuberculosis infection (LTBI) to b...